Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

211 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis?
Robinson WH, Genovese MC, Moreland LW. Robinson WH, et al. Among authors: genovese mc. Arthritis Rheum. 2001 Sep;44(9):1977-83. doi: 10.1002/1529-0131(200109)44:9<1977::AID-ART345>3.0.CO;2-6. Arthritis Rheum. 2001. PMID: 11592357 Free article. Review. No abstract available.
Unlocking the "PAD" lock on rheumatoid arthritis.
Utz PJ, Genovese MC, Robinson WH. Utz PJ, et al. Among authors: genovese mc. Ann Rheum Dis. 2004 Apr;63(4):330-2. doi: 10.1136/ard.2003.015990. Ann Rheum Dis. 2004. PMID: 15020322 Free PMC article. No abstract available.
A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis.
Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC, Genovese MC, Wasko MC, Moreland LW, Weaver AL, Markenson J, Finck BK. Bathon JM, et al. Among authors: genovese mc. N Engl J Med. 2000 Nov 30;343(22):1586-93. doi: 10.1056/NEJM200011303432201. N Engl J Med. 2000. PMID: 11096165 Free article. Clinical Trial.
Subcutaneous abatacept versus intravenous abatacept: a phase IIIb noninferiority study in patients with an inadequate response to methotrexate.
Genovese MC, Covarrubias A, Leon G, Mysler E, Keiserman M, Valente R, Nash P, Simon-Campos JA, Porawska W, Box J, Legerton C 3rd, Nasonov E, Durez P, Aranda R, Pappu R, Delaet I, Teng J, Alten R. Genovese MC, et al. Arthritis Rheum. 2011 Oct;63(10):2854-64. doi: 10.1002/art.30463. Arthritis Rheum. 2011. PMID: 21618201 Free PMC article. Clinical Trial.
Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to at least one tumor necrosis factor inhibitor: results of a forty-eight–week randomized, double-blind, placebo-controlled, parallel-group phase III trial.
Tak PP, Mease PJ, Genovese MC, Kremer J, Haraoui B, Tanaka Y, Bingham CO 3rd, Ashrafzadeh A, Travers H, Safa-Leathers S, Kumar S, Dummer W. Tak PP, et al. Among authors: genovese mc. Arthritis Rheum. 2012 Feb;64(2):360-70. doi: 10.1002/art.33353. Arthritis Rheum. 2012. PMID: 22389919 Free article. Clinical Trial.
211 results